Journal article icon

Journal article

Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis

Abstract:
Rho-associated kinases 1 and 2 (ROCK1/2) are Rho-GTPase effectors that control key aspects of the actin cytoskeleton, but their role in proliferation and cancer initiation or progression is not known. Here, we provide evidence that ROCK1 and ROCK2 act redundantly to maintain actomyosin contractility and cell proliferation and that their loss leads to cell-cycle arrest and cellular senescence. This phenotype arises from down-regulation of the essential cell-cycle proteins CyclinA, CKS1 and CDK1. Accordingly, while the loss of either Rock1 or Rock2 had no negative impact on tumorigenesis in mouse models of non-small cell lung cancer and melanoma, loss of both blocked tumor formation, as no tumors arise in which both Rock1 and Rock2 have been genetically deleted. Our results reveal an indispensable role for ROCK, yet redundant role for isoforms 1 and 2, in cell cycle progression and tumorigenesis, possibly through the maintenance of cellular contractility
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.7554/elife.12203

Authors

More by this author
Role:
Author
ORCID:
0000-0002-5099-8070
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3896-0827
More by this author
Role:
Author
ORCID:
0009-0005-5450-8496
More by this author
Role:
Author
ORCID:
0000-0003-2888-4314


Publisher:
eLife Sciences Publications
Journal:
eLife More from this journal
Volume:
5
Pages:
e12994-e12994
Publication date:
2016-01-14
DOI:
EISSN:
2050-084X
ISSN:
2050-084X


Language:
English
Keywords:
Pubs id:
2371246
Local pid:
pubs:2371246
Source identifiers:
W2278220345
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP